Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Metastatic colorectal cancer patients with certain BRAF mutations may respond to anti-EGFR therapy

Patients with metastatic colorectal cancer harboring a subset of non-V600 mutations in the BRAF gene, known as class 3 BRAF mutations, were more likely to respond to anti-EGFR treatment.

12 Sep 2019

ECLS trial demonstrates potential of blood test for early lung cancer detection

Oncimmune Holdings plc, a leading global immunodiagnostics group, welcomes the presentation of data today by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis.

12 Sep 2019

Cancer disease incidence and severity influenced by gene mutation, tissue location

The KRAS gene is one of the commonly mutated genes in cancer. More than 40 percent of colorectal cancers have a mutated KRAS gene, or oncogene, that is at least partially responsible for cancer development.

12 Sep 2019

New liquid biopsy test may be more predictive of patient's immunotherapy response

A new liquid biopsy test could detect microsatellite instability (MSI) and tumor mutational burden (TMB), indicating that it could help determine which patients are likely to respond to immune checkpoint inhibitors.

11 Sep 2019

Gut microbiome could be used to predict individual's risk of bowel cancer

The makeup of the bacterial community that lives in the gut has been identified as a risk factor for bowel cancer.

10 Sep 2019

New $3.75 million grant to support second phase of Indiana Geriatrics Workforce Enhancement Program

With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.

4 Sep 2019

Offering more testing choices does not boost colorectal cancer screening rates

Offering patients the choice between home screening or in-office colonoscopy does not increase participation in colorectal cancer screening, according to a new Penn Medicine study.

30 Aug 2019

Genetically altering protein in colon cancer cells may enhance efficacy of chemotherapy

Colorectal cancer outcomes may improve by genetically altering an immune-regulatory protein in cancer cells, making the cells more vulnerable to chemotherapy. That's according to new Mayo Clinic research.

27 Aug 2019

Sea snail compound shows potential as new anti-cancer pharmaceutical

The remarkable ability of a small Australian sea snail to produce a colorful purple compound to protect its eggs is proving even more remarkable for its potential in a new anti-cancer pharmaceutical.

27 Aug 2019

NIH announces new round of funding for Research Centers in Minority Institutions

The National Institute on Minority Health and Health Disparities, part of the National Institutes of Health, has funded three new awards and renewed the awards of eight institutions previously funded under the Research Centers in Minority Institutions Specialized Centers program.

26 Aug 2019

Sending reminders and text instructions increases rate of colonoscopies

Having simple text conversations with patients one week before they are scheduled for a colonoscopy dramatically decreased the "no-show" rates, according to a recent study conducted by Penn Medicine researchers.

26 Aug 2019

Researchers take important step towards preventing cancer metastasis

Researchers at the Paul Scherrer Institute, together with colleagues from the pharmaceutical company F. Hoffmann-La Roche AG, have taken an important step towards the development of an agent against the metastasis of certain cancers.

23 Aug 2019

Single course of antibiotics may boost colon cancer risk

In an extensive "data mining" analysis of British medical records, researchers at the Johns Hopkins Kimmel Cancer Center conclude that taking even a single course of antibiotics might boost--albeit slightly--the risk of developing colon cancer--but not rectal cancer--a decade later.

22 Aug 2019

PCORI approves fund to find best ways to treat conditions that impose high burdens

The Patient-Centered Outcomes Research Institute Board of Governors today approved $29.3 million to fund 11 studies comparing the best ways to prevent or treat a range of health conditions that impose high burdens on patients, caregivers and the healthcare system.

21 Aug 2019

Cancer survivors could be at greater risk of cardiovascular diseases

Over the last few decades, medical progress has led to the survival of many more people with cancer. However, a new study published in The Lancet shows that this cohort has a higher risk of cardiovascular disease (CVD) than controls without cancer, due to a number of reasons.

21 Aug 2019

Physical activity in adolescence associated with 39% reduction in risk of colorectal adenoma

The effects of more than 60 minutes of moderate daily physical exercise, such as walking, accumulate throughout life and are associated with a 39% reduction in the risk of advanced adenomatous polyps, a precursor of colorectal cancer, the third most frequent type of cancer in Brazil.

19 Aug 2019

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million.

14 Aug 2019

Study shows potential of crucial signaling pathway as biomarker, therapeutic target for cancer

A crucial signaling pathway that can tell the immune system to fight off cancer can also be co-opted by cancer cells to put the brakes on the immune system, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.

9 Aug 2019

Younger colorectal cancer patients experience delays in care leading to emergency diagnoses

In an analysis of information on 10,463 UK patients diagnosed with colorectal cancer from 2006 to 2013, patients under the age of 50 years were more likely to initially experience non-specific symptoms before being referred to cancer specialists.

7 Aug 2019

iTHRIV and community groups partner to address health needs across Virginia

Four biomedical research projects to improve the health of Virginians will be funded by the integrated Translational Health Research Institute of Virginia (iTHRIV), a Clinical Translational Science Award Hub.

5 Aug 2019

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Metastatic colorectal cancer patients with certain BRAF mutations may respond to anti-EGFR therapy

ECLS trial demonstrates potential of blood test for early lung cancer detection

Cancer disease incidence and severity influenced by gene mutation, tissue location

New liquid biopsy test may be more predictive of patient's immunotherapy response

Gut microbiome could be used to predict individual's risk of bowel cancer

New $3.75 million grant to support second phase of Indiana Geriatrics Workforce Enhancement Program

Offering more testing choices does not boost colorectal cancer screening rates

Genetically altering protein in colon cancer cells may enhance efficacy of chemotherapy

Sea snail compound shows potential as new anti-cancer pharmaceutical

NIH announces new round of funding for Research Centers in Minority Institutions

Sending reminders and text instructions increases rate of colonoscopies

Researchers take important step towards preventing cancer metastasis

Single course of antibiotics may boost colon cancer risk

PCORI approves fund to find best ways to treat conditions that impose high burdens

Cancer survivors could be at greater risk of cardiovascular diseases

Physical activity in adolescence associated with 39% reduction in risk of colorectal adenoma

Roswell Park receives more than $15 million in grants for cancer research

Study shows potential of crucial signaling pathway as biomarker, therapeutic target for cancer

Younger colorectal cancer patients experience delays in care leading to emergency diagnoses

iTHRIV and community groups partner to address health needs across Virginia

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in